Fatty acid binding protein 7 may be a marker and therapeutic targets in clear cell renal cell carcinoma

被引：0
|
作者：
Kazuhiro Nagao
Nachi Shinohara
Frank Smit
Mirjam de Weijert
Sander Jannink
Yuji Owada
Peter Mulders
Egbert Oosterwijk
Hideyasu Matsuyama
机构：
[1] Yamaguchi University,Department of Urology, Graduate School of Medicine
[2] Radboud University Medical Center,Department of Urology
[3] Tohoku University Graduate School of Medicine,Department of Organ Anatomy
来源：
BMC Cancer | / 18卷
关键词：
Fatty acid binding protein 7; Clear cell renal cell carcinoma; Prognostic marker; Therapeutic target; Fatty acid binding protein 6;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Modeling clear cell renal cell carcinoma and therapeutic implications
    Melissa M. Wolf
    W. Kimryn Rathmell
    Kathryn E. Beckermann
    [J]. Oncogene, 2020, 39 : 3413 - 3426
  • [32] Vascular Expression of PDGFR-β Isoform in Clear Cell Renal Cell Carcinoma: A Potential Therapeutic Marker?
    Petit, A.
    Gaspa, A.
    Garcia-Albeniz, X.
    Nadal, A.
    Mellado, B.
    Mallofre, C.
    [J]. LABORATORY INVESTIGATION, 2009, 89 : 189A - 189A
  • [33] Orellanine specifically targets renal clear cell carcinoma
    Buvall, Lisa
    Hedman, Heidi
    Khramova, Alina
    Najar, Deman
    Bergwall, Lovisa
    Ebefors, Kerstin
    Sihlbom, Carina
    Lundstam, Sven
    Herrmann, Anders
    Wallentin, Hanna
    Roos, Emelie
    Nilsson, Ulf A.
    Johansson, Martin
    Tornell, Jan
    Haraldsson, Borje
    Nystrom, Jenny
    [J]. ONCOTARGET, 2017, 8 (53) : 91085 - 91098
  • [34] A Fatty Acid Metabolism Signature Associated With Clinical Therapy in Clear Cell Renal Cell Carcinoma
    Wei, Zhihao
    Cheng, Gong
    Ye, Yuzhong
    Le, Changjie
    Miao, Qi
    Chen, Jiawei
    Yang, Hongmei
    Zhang, Xiaoping
    [J]. FRONTIERS IN GENETICS, 2022, 13
  • [35] TEK is a novel prognostic marker for clear cell renal cell carcinoma
    Ha, M.
    Son, Y. R.
    Kim, J.
    Park, S. M.
    Hong, C. M.
    Choi, D.
    Kang, W.
    Kim, J. H.
    Lee, K. J.
    Park, D.
    Han, M. E.
    Oh, S. O.
    Lee, D.
    Kim, Y. H.
    [J]. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 (04) : 1451 - 1458
  • [36] Chemokines as therapeutic targets in renal cell carcinoma
    Reckamp, Karen L.
    Strieter, Robert M.
    Figlin, Robert A.
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (06) : 887 - 893
  • [37] Evolving therapeutic targets in renal cell carcinoma
    Singer, Eric A.
    Gupta, Gopal N.
    Marchalik, Daniel
    Srinivasan, Ramaprasad
    [J]. CURRENT OPINION IN ONCOLOGY, 2013, 25 (03) : 273 - 280
  • [38] AHNAK2 is a Novel Prognostic Marker and Oncogenic Protein for Clear Cell Renal Cell Carcinoma
    Wang, Minglei
    Li, Xuefeng
    Zhang, Jin
    Yang, Qiong
    Chen, Wenqi
    Jin, Weilin
    Huang, Yi-Ran
    Yang, Ru
    Gao, Wei-Qiang
    [J]. THERANOSTICS, 2017, 7 (05): : 1100 - 1113
  • [39] Gene expression profiling tumors of patients with clear cell renal carcinoma: May identify race-specific therapeutic targets
    Reams, Romonia Renee
    Heyliger, Simone O.
    Saulsbury, Marilyn
    Taioli, Emanuela
    Wilkie, Diana
    Carpten, John
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2023, 32 (12)
  • [40] Comprehensive Genomic Analysis of Metastatic Non-Clear-Cell Renal Cell Carcinoma to Identify Therapeutic Targets
    Carlo, Maria, I
    Khan, Nabeela
    Zehir, Ahmet
    Patil, Sujata
    Ged, Yasser
    Redzematovic, Almedina
    Coskey, Devyn T.
    Hyman, David M.
    Ladanyi, Marc
    Chen, Ying-Bei
    Robson, Mark
    Hakimi, A. Ari
    Lee, Chung-Han
    Feldman, Darren R.
    Gao, Jianjiong
    Chakravarty, Debyani
    Motzer, Robert J.
    Voss, Martin H.
    [J]. JCO PRECISION ONCOLOGY, 2019, 3 : 1 - 18
12345